No Preemption In Blood Pressure Drug Contamination MDL

By Mike Curley · December 18, 2020, 10:11 PM EST

A New Jersey federal judge won't let manufacturers, wholesalers and pharmacies escape multidistrict litigation over their alleged failure to keep contamination out of the blood pressure drug Valsartan, saying federal law...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION

Case Number

1:19-md-02875

Court

New Jersey

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

February 14, 2019